BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31690669)

  • 1. Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.
    Bhattacharya U; Gutter-Kapon L; Kan T; Boyango I; Barash U; Yang SM; Liu J; Gross-Cohen M; Sanderson RD; Shaked Y; Ilan N; Vlodavsky I
    Cancer Res; 2020 Jan; 80(1):57-68. PubMed ID: 31690669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase is required for activation and function of macrophages.
    Gutter-Kapon L; Alishekevitz D; Shaked Y; Li JP; Aronheim A; Ilan N; Vlodavsky I
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7808-E7817. PubMed ID: 27849593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
    Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of host heparanase in promoting tumor growth and metastasis.
    Zhang GL; Gutter-Kapon L; Ilan N; Batool T; Singh K; Digre A; Luo Z; Sandler S; Shaked Y; Sanderson RD; Wang XM; Li JP; Vlodavsky I
    Matrix Biol; 2020 Nov; 93():25-42. PubMed ID: 32534153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme.
    Hermano E; Meirovitz A; Meir K; Nussbaum G; Appelbaum L; Peretz T; Elkin M
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25326645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase expression is associated with histone modifications in glioblastoma.
    Hong X; Nelson K; Lemke N; Kalkanis SN
    Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells.
    Jiang G; Zheng L; Pu J; Mei H; Zhao J; Huang K; Zeng F; Tong Q
    PLoS One; 2012; 7(2):e31379. PubMed ID: 22363633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
    Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
    Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.
    Ramani VC; Vlodavsky I; Ng M; Zhang Y; Barbieri P; Noseda A; Sanderson RD
    Matrix Biol; 2016 Sep; 55():22-34. PubMed ID: 27016342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes.
    He YQ; Sutcliffe EL; Bunting KL; Li J; Goodall KJ; Poon IK; Hulett MD; Freeman C; Zafar A; McInnes RL; Taya T; Parish CR; Rao S
    Transcription; 2012; 3(3):130-45. PubMed ID: 22771948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.
    Blich M; Golan A; Arvatz G; Sebbag A; Shafat I; Sabo E; Cohen-Kaplan V; Petcherski S; Avniel-Polak S; Eitan A; Hammerman H; Aronson D; Axelman E; Ilan N; Nussbaum G; Vlodavsky I
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e56-65. PubMed ID: 23162016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of heparanase 2 (Hpa2) in gastric cancer.
    Liu J; Knani I; Gross-Cohen M; Hu J; Wang S; Tang L; Ilan N; Yang S; Vlodavsky I
    Neoplasia; 2021 Sep; 23(9):966-978. PubMed ID: 34343822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.
    Lerner I; Hermano E; Zcharia E; Rodkin D; Bulvik R; Doviner V; Rubinstein AM; Ishai-Michaeli R; Atzmon R; Sherman Y; Meirovitz A; Peretz T; Vlodavsky I; Elkin M
    J Clin Invest; 2011 May; 121(5):1709-21. PubMed ID: 21490396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression.
    Singh P; Blatt A; Feld S; Zohar Y; Saadi E; Barki-Harrington L; Hammond E; Ilan N; Vlodavsky I; Chowers Y; Half E
    Neoplasia; 2017 Mar; 19(3):175-184. PubMed ID: 28147305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water extract of ginseng and astragalus regulates macrophage polarization and synergistically enhances DDP's anticancer effect.
    Chen Y; Bi L; Luo H; Jiang Y; Chen F; Wang Y; Wei G; Chen W
    J Ethnopharmacol; 2019 Mar; 232():11-20. PubMed ID: 30529424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse macrophages polarization in tumor microenvironment.
    Rhee I
    Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase Accelerates Obesity-Associated Breast Cancer Progression.
    Hermano E; Goldberg R; Rubinstein AM; Sonnenblick A; Maly B; Nahmias D; Li JP; Bakker MAH; van der Vlag J; Vlodavsky I; Peretz T; Elkin M
    Cancer Res; 2019 Oct; 79(20):5342-5354. PubMed ID: 31481501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
    Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
    Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.
    Ramani VC; Zhan F; He J; Barbieri P; Noseda A; Tricot G; Sanderson RD
    Oncotarget; 2016 Jan; 7(2):1598-607. PubMed ID: 26624982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.